Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 13,244 shares at $28.14 ($376K) on 2017-09-29, disclosed to the SEC on 2017-09-29.
Open-market sale of $376k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.12 | 1,700 | $48K | 12.7% |
| 2 | $28.14 | 1,800 | $51K | 13.5% |
| 3 | $28.31 | 4,244 | $120K | 32.0% |
| 4 | $28.31 | 4,244 | $120K | 32.0% |
| 5 | $29.24 | 200 | $6K | 1.6% |
| 6 | $29.26 | 300 |
| $9K |
| 2.3% |
| 7 | $29.32 | 756 | $22K | 5.9% |
| Total | $28.36 avg | 13,244 | $376K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |